Form C - Offering Statement:
SEC Accession No. 0001665160-22-000559
Filing Date
2022-03-28
Accepted
2022-03-28 14:53:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 9209
2 offeringmemoformc.pdf EX-99 45514356
  Complete submission text file 0001665160-22-000559.txt   62691538
Mailing Address 325 RUTLEDGE STREET BROOKLYN NY 11211
Business Address 515 MADISON AVENUE NEW YORK NY 10022 917-930-4332
Fisher Wallace Laboratories, Inc. (Filer) CIK: 0001787792 (see all company filings)

EIN.: 208131183 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-29929 | Film No.: 22775067
SIC: 3841 Surgical & Medical Instruments & Apparatus